Aon Expands Ferrari Partnership into High-Performance Sailing, Promoting Innovation and Resilience

MILAN, Feb. 17, 2026 /PRNewswire/ — Aon plc (NYSE: AON), a leading global professional services firm, today announced that it will serve as the Premium Partner of Ferrari Hypersail, an unprecedented marine initiative dedicated to high-performance sailing.

In 2025, Aon became an Official Partner of the Scuderia Ferrari HP Formula One team through a multi-year agreement. By extending their relationship from the racetrack to the water, Aon aims to demonstrate how resilience and better decision-making can unlock new possibilities for clients and set new standards in competitive sport. This partnership will come to life through brand applications across the boat, crew uniforms and global event integrations.

“We’re excited to join Ferrari on this innovative journey into offshore sailing,” said Carlo Clavarino, executive chairman of international business for Aon. “Ocean racing is all about making smart, real-time decisions in the face of uncertainty. By combining our data‑driven insights with Ferrari’s engineering excellence, we’re charting new paths in engineering and risk management. It’s a fantastic opportunity to work together and drive real innovation.”

Developed to explore new frontiers of innovation, self-sufficiency and performance in ocean racing, this 30-meter monohull prototype combines advanced engineering with a design focused on stability, using three points of contact. The boat generates all of its own power while underway and is powered entirely by renewable energy. Its key innovation is the integration of a canting keel equipped with a foil which acts as a support point during flight, supported by a rudder and two lateral foils.

The initiative is led by Giovanni Soldini, a world-renowned sailing pioneer and Team Principal, whose long-standing collaboration with Aon brings deep expertise to this new venture. Currently under construction in Italy, the boat is set to launch in 2026, with sea trials commencing shortly afterward.

“We are very proud to stand alongside Ferrari in this innovative project. With Ferrari Hypersail, we are taking a step further: thanks to the strength of the Ferrari brand and the international dimension of the project, we are broadening our reach and bringing the story of innovation, sustainability and risk management to an even wider audience made up of all size companies, sports enthusiasts, innovators and new generations,” said Andrea Parisi, CEO of Italy and Eastern Mediterranean for Aon. “Partnering with Ferrari — on the racetrack and now on the water — provides Aon with a unique opportunity to engage our clients in new and meaningful ways, bringing them closer to innovation and the spirit of exploration.”

“Hypersail represents a new platform for Ferrari to develop meaningful partnerships that extend beyond visibility and are rooted in shared values and expertise,” said Lorenzo Giorgetti, Chief Racing Revenues Officer of Ferrari. “Aon is a natural partner for a project of this scale, taking an active role at the heart of the initiative and helping shape a living ecosystem where performance and risk management are essential elements.”

“Ferrari Hypersail is a project with an exceptionally high level of research and innovation, exploring completely unprecedented scenarios,” said Antonio Picca Piccon, CFO of Ferrari. “Having Aon onboard as a partner represents a significant added value, thanks to its strong expertise in risk management and its previous experience in ocean racing.”

About Aon
Aon plc (NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues provide clients in over 120 countries with the clarity and confidence to make better risk and people decisions that protect and grow their businesses.

Follow Aon on LinkedIn, X, Facebook and Instagram. Stay up-to-date by visiting Aon’s Newsroom and sign up for news alerts here.

Aon Media Contact
mediainquiries@aon.com
Toll-free (U.S., Canada and Puerto Rico): +1 833 751 8114
International: +1 312 381 3024

Aon plc (NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Through actionable analytic insight, globally integrated Risk Capital and Human Capital expertise, and locally relevant solutions, our colleagues in over 120 countries provide our clients with the clarity and confidence to make better risk and people decisions that protect and grow their businesses. Follow Aon on LinkedIn, X, Facebook and Instagram. Stay up-to-date by visiting Aon’s newsroom and sign up for news alerts here.

Metabolomics-Derived Pathway Scores Outperform Inflammatory Protein Markers—Delivering Risk Prediction Where Proteomics Falls Short

MORRISVILLE, N.C., Feb. 17, 2026 /PRNewswire/ — Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, today announced its industry-leading global metabolomics platform was used by researchers from Kite, a Gilead company, for the most extensive metabolomic study ever conducted in the context of CAR T-cell therapy. Leveraging Metabolon’s untargeted Global Discovery Panel, Kite researchers analyzed more than 3,800 longitudinal serum and plasma samples—and a rare set of cerebrospinal fluid (CSF) samples—from patients treated with the FDA-approved anti-CD19 CAR T-cell therapies axicabtagene ciloleucel (axi-cel) and brexucabtagene autoleucel (brexu-cel).

The multi-trial meta-cohort, spanning six clinical studies, enabled investigators to uncover metabolic pathways strongly associated with severe neurological events (NEs), a significant and sometimes life-threatening toxicity of CAR T-cell therapy. Despite the transformative efficacy of CAR T-cell treatments for large B-cell lymphoma (LBCL), mantle cell lymphoma, follicular lymphoma, and B-cell acute lymphoblastic leukemia, the biological drivers of neurotoxicity have remained poorly understood.

“This study demonstrates how metabolomics uniquely exposes the biological pathways driving CAR T-cell–associated neurotoxicity, insights that are not accessible through proteomics or cytokine profiling alone,” said Heino Heyman, Director of Global Field Metabolomics Sciences at Metabolon. “By mapping disruptions in tryptophan catabolism, NMDA-linked excitotoxicity, and polyamine metabolism, the analysis not only identified patients at risk for severe neurologic events but also highlighted actionable pathway targets to mitigate toxicity. These findings demonstrate that metabolomics provides a functional, pathway-level understanding of safety and patient response, which is crucial for enhancing cell therapy design, monitoring strategies, and clinical outcomes.”

Using Metabolon’s high-resolution metabolomics platform, researchers identified clear and reproducible metabolic signatures that distinguished patients who developed high-grade NEs (grade ≥ 3). Notable findings include:

• Elevated Tryptophan Breakdown Signals Higher Neurotoxicity Risk – Patients who developed severe neurological events consistently showed higher breakdown of tryptophan, leading to increased levels of metabolites, such as quinolinate. These markers were present both before and after treatment and are strongly associated with heightened neurotoxicity risk.
• Increased Arginine Pathway Activity Reflects Heightened Immune Stress – Severe cases also showed a shift in how the body processes arginine, resulting in the production of more urea and acetylated polyamines, such as N1, N12-diacetylspermine. This pattern reflects increased immune system activation and may serve as another indicator of neurotoxicity risk.
• CSF Findings Confirm Metabolic Disruption in the Brain – Cerebrospinal fluid samples taken during neurotoxic events showed the same metabolic disruptions observed in blood—higher levels of glutamate and other stress-related metabolites—confirming that these changes directly involve the central nervous system.
• Metabolite-Based Scores Predict Neurotoxicity Better Than Traditional Markers – New metabolic pathway scores built from these biomarkers outperformed standard inflammatory markers (such as IL-6 and TNFα) in identifying patients at risk for severe neurological events. This demonstrates the potential for more accurate, metabolomics-driven early warning tools.
• Key Metabolites Also Track with Disease Progression – The same metabolites linked to neurotoxicity—such as quinolinate and acetylated polyamines—were also associated with worse disease outcomes. Machine-learning models reinforced the importance of the tryptophan-kynurenine pathway for neurotoxicity associated with CAR T cell therapy.

“These findings underscore the power of metabolomics to reveal mechanisms that are invisible to genomic, proteomic, and cellular assays alone,” said Ro Hastie, CEO of Metabolon. “By enabling unprecedented resolution into metabolic dysfunction associated with CAR T-cell therapy, Metabolon’s platform has helped identify new biomarkers and potential therapeutic targets to mitigate severe neurotoxicity.”

To learn more about Metabolon’s industry-leading Global Discovery Panel, please visit: https://www.metabolon.com/services/untargeted-metabolomics/global-panel/

About Metabolon 
Metabolon, Inc. is the global leader in metabolomics, with a mission to deliver biochemical data and insights that expand and accelerate the impact of life sciences research and complement other ‘omics’ technologies. With 25 years of experience, 15,000+ client projects, 4,000+ scientific publication references, and ISO 9001:2015, CLIA, and CAP certifications, Metabolon has developed industry-leading scientific, technology, and bioinformatics techniques. Metabolon’s Global Discovery Panel is powered by the world’s largest proprietary metabolomics reference library. Metabolon’s industry-leading data and translational science expertise help customers and partners address some of the most challenging and pressing questions in the life sciences, accelerating research and enhancing development success. The company offers scalable, customizable multiomics solutions, including metabolomics and lipidomics, that support customer needs from discovery through clinical trials and product life-cycle management. For more information, please visit www.metabolon.com and follow us on LinkedIn and Twitter.

About Metabolomics
Metabolomics, the large-scale study of all small molecules in a biological system, is the only omics technology that provides a complete current-state functional readout of a biological system. Metabolomics enables researchers to see beyond the genetic variation of individuals, capturing the combined impact of genetic and environmental factors, including the effects of drugs, diet, lifestyle, and the microbiome, on human health. By measuring thousands of discrete chemical signals that form biological pathways in the body, metabolomics can reveal important biomarkers, enabling a better understanding of a drug’s mechanism of action, pharmacodynamics, and safety profile, as well as individual responses to therapy.

LOS ANGELES, Feb. 17, 2026 /PRNewswire/ — TWOPAGES Curtains, a pioneer in modern window treatment solutions, has announced the launch of its 2026 global campaign, the “TWOPAGES Curtain Glow Up Challenge.” Running till March 31, 2026, the challenge invites creators worldwide to reimagine interior spaces through the transformative power of window treatments.

Participation is straightforward: creators complete a space refresh using TWOPAGES products and share before-and-after images or videos on social media. Submissions will be evaluated across multiple dimensions, including creative expression, the impact of the transformation, and overall content resonance. To encourage broad participation, the challenge features multiple award categories designed to recognize different creative formats and experience levels, with the top prize reaching USD 10,000.

Video Case Studies:

1. Full Room Transformation 
   https://www.instagram.com/p/DEsI1PYJmWM/
2. Curtain-Only Transformation 
   https://www.instagram.com/p/DC1xSkSOyvf/ 
3. Before & After Comparison 
   https://www.instagram.com/reel/DQaJ-8wDlEG/ 

Open to creators across home décor, interior design, and lifestyle content categories, the challenge reflects TWOPAGES’ growing influence and community-driven approach as the brand approaches its 11th anniversary. In North America, TWOPAGES has seen steady momentum, with year-over-year Instagram follower growth exceeding 20% and dozens of daily posts tagging @twopagescurtains. Over the past year alone, more than 5,000 creators and influencers have actively collaborated with the brand, forming a dynamic ecosystem around home styling and visual inspiration.

The campaign was conceived to further energize this creative community while injecting new vitality into home décor content. By positioning curtains as a starting point for spatial transformation, the challenge highlights how a single design element can redefine atmosphere, functionality, and personal expression within a space. Through authentic, user-generated content, TWOPAGES aims to spotlight diverse interpretations of “glow up” moments, from subtle refreshes to dramatic visual changes.

The Curtain Glow Up Challenge underscores TWOPAGES’ commitment to supporting creativity beyond traditional marketing, offering creators a platform where design ideas, personal style, and storytelling intersect. It also reflects the brand’s belief that home décor content thrives when it is accessible, visually engaging, and rooted in everyday living spaces. Creators and home décor enthusiasts can find full details and submission guidelines at https://TWOPAGEScurtains.com/pages/TWOPAGES-curtain-glow-up-challenge.

About TWOPAGES

Founded in 2015, TWOPAGES is a global home décor brand dedicated to creating premium, customizable window treatment solutions. By combining craftsmanship and innovation, TWOPAGES simplifies the curtain-shopping experience through smart measurement tools, virtual consultations, and fast delivery. 

DUBAI, UAE, Feb. 17, 2026 /PRNewswire/ — Asia Bankers Club has appointed Ian Banerjee as Managing Director, coinciding with the opening of its Dubai Global Office, as the group speeds up its expansion and further embeds its presence in the Middle East.

The Dubai Global Office will be a key connectivity hub between the west and the east with a particular emphasis on facilitating investment, entrepreneurship, and business setup and market entry across the region.

Ian has global leadership experience in entrepreneurship, alternative assets, and the cruise and maritime real estate industry. Most recently, he was affiliated with Crescent Seas – A Miami based company as Sales Director for Strategic Partnerships, where he was involved in a groundbreaking global residential real estate project at sea, marrying luxury lifestyle, mobility, and long-term asset ownership. His Miami-to-Dubai move is consistent with a globally mobile business and investment strategy.

“Asia Bankers Club welcomes Ian’s appointment as a major step in its global expansion plans,” said Kingston Lai, Founder & CEO of Asia Bankers Club. “Ian’s global outlook, entrepreneurial spirit, and experience makes him an outstanding candidate to build our Dubai Global Office and facilitate global connectivity to Asia, the Middle East, Africa, and India.”

Since its inception in 2012, Asia Bankers Club has evolved into a worldwide network of over 100,000 entrepreneurs, investors, and innovators in finance, technology, real assets, and new sectors. The group was established by Kingston Lai, former Executive Director at Morgan Stanley, and is invested by Black Spade Capital, the family office of Lawrence Ho, Chairman and CEO of Melco Resorts & Entertainment.

The Dubai office will concentrate on Middle East business setup and market entry solutions for companies, entrepreneurs, institutional investors, wealth funds, family offices, and private capital groups. This will include end-to-end services such as regional strategy, licensing, local partnerships, capital introductions, and residency options such as Golden Visas.

Speaking about the new Dubai office, Ian said, “Dubai is no longer a regional hub but a global command center for capital and entrepreneurship. The launch of the Global Office in Dubai will enable us to connect Asia, the Middle East, Africa, and India, allowing Western capital and businesses to tap into Eastern growth sectors with ease, stability, and scalability.”

Media Contact:
Asia Bankers Club – Global Office, Dubai
vivian.chen@asiabankersclub.com
https://www.asiabankersclub.com/press_release/ustour/ 

Bitmine has 3,040,483 staked ETH, representing $6.1 billion at $1,998 per ETH; MAVAN staking solution on track to launch Q1 2026

Bitmine now owns 3.62% of the ETH token supply, over 72% of the way to the ‘Alchemy of 5%’ in just 7 months

Bitmine recently closed on initial $200 million investment into Beast Industries

Bitmine Crypto + Total Cash Holdings + “Moonshots” total $9.6 billion, including 4.371 million ETH tokens, total cash of $670 million, and other crypto holdings

Bitmine leads crypto treasury peers by both the velocity of raising crypto NAV per share and by the high trading liquidity of BMNR stock

Bitmine is the 158th most traded stock in the US, trading $0.9 billion per day (5-day avg)

Bitmine remains supported by a premier group of institutional investors including ARK’s Cathie Wood, MOZAYYX, Founders Fund, Bill Miller III, Pantera, Kraken, DCG, Galaxy Digital and personal investor Thomas “Tom” Lee to support Bitmine’s goal of acquiring 5% of ETH

LAS VEGAS, Feb. 17, 2026 /PRNewswire/ — (NYSE AMERICAN: BMNR) Bitmine Immersion Technologies, Inc. (“Bitmine” or the “Company”) a Bitcoin and Ethereum Network company with a focus on the accumulation of crypto for long term investment, today announced Bitmine crypto + total cash + “moonshots” holdings totaling $9.6 billion.

As of February 16th, 2026 at 5:00pm ET, the Company’s crypto holdings are comprised of 4,371,497 ETH at $1,998 per ETH (NASDAQ: COIN), 193 Bitcoin (BTC), $200 million stake in Beast Industries, $17 million stake in Eightco Holdings (NASDAQ: ORBS) (“moonshots”) and total cash of $670 million. Bitmine’s ETH holdings are 3.62% of the ETH supply (of 120.7 million ETH).

“After spending the past week at Consensus Hong Kong, one of the largest global gatherings in crypto, we came away with a growing conviction that 2026 will be a defining year for Ethereum. We see strengthening product-market fit emerging on the back of three long-duration secular drivers: (i) Wall Street via tokenization/privacy on Ethereum; (ii) AI and AI-agents using Ethereum for both collecting payments as well as verification and (iii) creators leaning towards ‘proof of human’ and other standards running on Ethereum L2 (Worldchain, etc). There were many panel discussions and presentations around these 3 topics, and it is evident that Ethereum is well positioned to garner significant share, given its neutrality and 100% uptime and reliability,” said Thomas “Tom” Lee, Chairman of Bitmine.

Mr. Lee’s latest Chairman’s message is his keynote given at Consensus HK, and he speaks about these 3 future growth drivers for ETH usage as well as the drivers for Bitmine growth initiatives. The link to his message is here.

“Investor sentiment and enthusiasm, by contrast, are rock bottom, reminding us of the forlornness and dejection seen at the November 2022 lows and depths of 2018 crypto winter. During 2018 and 2022, there were many high profile failures of large players (FTX, 3 arrows in 2022) while 2025-2026 has not seen such large-scale debacles. Rather, it seems like crypto has remained weak since the ‘price shock’ and massive deleveraging seen on October 10th. For us at Bitmine, we cannot control the price of Ethereum, and the company is acquiring ETH regardless of price trend, as the long-term outlook for Ethereum remains outstanding. Hence, we continue to buy ETH even as crypto moves through this ‘mini-winter,'” said Lee.

“In the past week, we acquired 45,759 ETH,” continued Lee. “Bitmine has been steadily buying Ethereum, as we view this pullback as attractive, given the strengthening fundamentals. In our view, the price of ETH is not reflective of the high utility of ETH and its role as the future of finance.”

As of February 16, 2026, Bitmine total staked ETH stands at 3,040,483 ($6.1 billion at $1,998 per ETH). “Bitmine has staked more ETH than other entities in the world. At scale (when Bitmine’s ETH is fully staked by MAVAN and its staking partners), the ETH staking rewards is $252 million annually (using 2.89% 7-day BMNR yield),” stated Lee.

“Annualized staking revenues are now $176 million. And this 3.0 million ETH is about 69% of the 4.37 million ETH held by Bitmine. The CESR (Composite Ethereum Staking Rate, administered by Quatrefoil) is 2.84%, while Bitmine’s own staking operations generated a 7-day yield of 2.89% (annualized). We continue to make progress on our staking solution known as The Made in America VAlidator Network (MAVAN). This will be the ‘best-in-class’ solution offering secure staking infrastructure and will be deployed in early calendar 2026. Bitmine is currently working with 3 staking providers as the Company moves towards unveiling MAVAN in 2026,” continued Lee.

Bitmine crypto holding reigns as the #1 Ethereum treasury and #2 global treasury, behind Strategy Inc. (NASDAQ: MSTR), which owns 714,644 BTC valued at $49 billion. Bitmine remains the largest ETH treasury in the world. 

Bitmine is one of the most widely traded stocks in the US. According to data from Fundstrat, the stock has traded average daily dollar volume of $0.9 billion (5-day average, as of February 13, 2026), ranking #158 in the US, behind KKR (rank #157) and ahead of CBRE (rank #159) among 5,704 US-listed stocks (statista.com and Fundstrat research).

The GENIUS Act and Securities and Exchange Commission’s (“the SEC”) Project Crypto are as transformational to financial services in 2025 as US action on August 15, 1971 ending Bretton Woods and the USD on the gold standard 54 years ago. This 1971 event was the catalyst for the modernization of Wall Street, creating the iconic Wall Street titans and financial and payment rails of today. These proved to be better investments than gold.

The Chairman’s message can be found here:
https://www.Bitminetech.io/chairmans-message

The Fiscal Full Year 2025 Earnings presentation and corporate presentation can be found here: https://Bitminetech.io/investor-relations/

To stay informed, please sign up at: https://Bitminetech.io/contact-us/

About Bitmine
Bitmine (NYSE AMERICAN: BMNR) is the leading Ethereum Treasury company in the world, implementing an innovative digital asset strategy for institutional investors and public market participants. Guided by its philosophy of “the alchemy of 5%,” the Company is committed to ETH as its primary treasury reserve asset, leveraging native protocol-level activities including staking and decentralized finance mechanisms. The Company will launch MAVAN (Made-in America VAlidator Network), a dedicated staking infrastructure for Bitmine assets, in Q1 of 2026.

For additional details, follow on X:
https://x.com/bitmnr
https://x.com/fundstrat
https://x.com/bmnrintern

Forward Looking Statements
This press release contains statements that constitute “forward-looking statements.” The statements in this press release that are not purely historical are forward-looking statements which involve risks and uncertainties. This document specifically contains forward-looking statements regarding progress and achievement of the Company’s goals regarding ETH acquisition and staking, the long-term value of Ethereum, continued growth and advancement of the Company’s Ethereum treasury strategy and the applicable benefits to the Company. In evaluating these forward-looking statements, you should consider various factors, including Bitmine’s ability to keep pace with new technology and changing market needs; Bitmine’s ability to finance its current business, Ethereum treasury operations and proposed future business; the competitive environment of Bitmine’s business; and the future value of Bitcoin and Ethereum. Actual future performance outcomes and results may differ materially from those expressed in forward-looking statements. Forward-looking statements are subject to numerous conditions, many of which are beyond Bitmine’s control, including those set forth in the Risk Factors section of Bitmine’s Form 10-K filed with the SEC on November 21, 2025, as well as all other SEC filings, as amended or updated from time to time. Copies of Bitmine’s filings with the SEC are available on the SEC’s website at www.sec.gov. Bitmine undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Bitmine Weekly Update

STAKING: BMNR now staking over 3 million ETH

ALCHEMY of 5%: BMNR ranked #158 by 5D avg daily $ volume

ONTARIO, Calif., Feb. 17, 2026 /PRNewswire/ — Nature’s Miracle Holding Inc. (“Nature’s Miracle,” “NMHI,” or the “Company”), a provider of equipment and services for the controlled environment agriculture (CEA) industry, today announced it has signed an exclusive supply agreement with Megaphoton USA LLC, a Los Angeles-based specialized manufacturer of grow lights. This strategic partnership strengthens Nature’s Miracle’s domestic supply chain capabilities while addressing growing customer demand for reliable, U.S.-manufactured CEA lighting solutions.

Under the agreement, Nature’s Miracle will offer its customers Made-in-USA grow light products under the newly-launched brand name “Nature’s Miracle.” These products will be manufactured in the United States by Megaphoton USA LLC.

Initial Product Offerings Include:
1000W Full Spectrum LED Grow Light
600W Full Spectrum LED Grow Light
277V 1000W HPS Grow Light Fixture
480V 1000W HPS Grow Light Fixture
DE 1000W HPS Grow Lamp

According to James Li, Chairman and CEO of NMHI:
“We are very excited about our partnership with Megaphoton, which gives us the ability to offer Made-in-USA grow light products to our customers. Nature’s Miracle will be one of the first to offer such products in the U.S. This will reduce uncertainty regarding tariffs and logistics associated with overseas sourcing. We will also be able to adapt to our customers’ needs on a real-time basis.”

About Nature’s Miracle Holding Inc.

Nature’s Miracle (www.Nature-Miracle.com) is an agriculture technology company providing equipment and services to the controlled environment agriculture industry, including vertical farming, in North America. Through its wholly owned subsidiaries, Visiontech Group, Inc. and Hydroman, Inc., the Company supplies grow lights and hydroponic products to indoor growers. The Company also evaluates opportunities to participate in commercial-scale greenhouse projects intended to support demand for locally produced food, subject to market conditions and the Company’s available capital resources. Through its wholly owned subsidiaries, Visiontech Group, Inc. and Hydroman, Inc., the Company supplies grow lights and hydroponic products to a broad base of indoor growers. Nature’s Miracle also maintains a pipeline of commercial-scale greenhouse projects intended to address the growing demand for fresh, locally produced food in North America.

Important Information About This Press Release

This press release contains information regarding supplier agreements and related terms. The terms of these agreements can change or can be amended from time to time. The ability of such suppliers to meet demand is not ascertained.

Statements attributed to the Company’s management reflect current views and expectations as of the date hereof and should not be interpreted as assurances, guarantees, or projections of future performance, results, or business activities, including any expansion into engineering, procurement, and construction (“EPC”) services.

This press release may include information regarding third parties and potential projects based on information provided by such third parties. The Company has not independently verified such information, and there can be no assurance that discussions will result in a definitive agreement or transaction.

This press release does not purport to contain all information necessary to evaluate the Company or its securities and is not intended to form the basis of any investment decision. Investors are encouraged to review the Company’s filings with the U.S. Securities and Exchange Commission (the “SEC”), available at www.sec.gov, for additional information, including risk factors.

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of the federal securities laws. Forward-looking statements include, but are not limited to, statements regarding anticipated benefits, future business prospects, growth strategies, market opportunities, and planned activities. These statements are generally identified by words such as “anticipate,” “believe,” “expect,” “may,” “could,” “will,” “potential,” “intend,” “estimate,” “should,” “plan,” or similar expressions.

Forward-looking statements are based on management’s current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied. Factors that could cause such differences include, but are not limited to: (i) the Company’s ability to generate revenue and execute its business strategy; (ii) risks related to market conditions and competitive pressures; (iii) changes in applicable laws and regulations; (iv) the Company’s ability to implement planned initiatives; and (v) broader economic and industry conditions.

Forward-looking statements speak only as of the date they are made. The Company undertakes no obligation to update or revise any forward-looking statements, except as required by law. Readers are cautioned not to place undue reliance on these statements.

Non-Solicitation

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under applicable securities laws. Any offer of securities will be made only by means of a prospectus that meets the requirements of the Securities Act of 1933, as amended.